CXCL10-armed oncolytic adenovirus promotes tumor-infiltrating T-cell chemotaxis to enhance anti-PD-1 therapy

Volume 11, Issue 1, December 2022 .

Source: OncoImmunology - August 31, 2022 Category: Cancer & Oncology Authors: Xiaofei Li Mingjie Lu Manman Yuan Jing Ye Wei Zhang Lingyan Xu Xiaohan Wu Bingqing Hui Yuchen Yang Bin Wei Ciliang Guo Min Wei Jie Dong Xingxin Wu Yanhong Gu Source Type: research